Last Updated on June 22, 2023

RSC Drug Discovery Series- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Royal Society of Chemistry

Abbreviation: RSC Drug Discov. Ser.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.28

SJR

 0.107

h-Index

 11

Rank

 25709

Important Details

Title RSC Drug Discovery Series
Standard Abbreviation RSC Drug Discov. Ser.
Type of Publication Book series
Discipline Drug Discovery (Q4)
Impact Score 0.28
SCImago Journal Rank (SJR) 0.107
h-index 11
Overall Rank 25709
Publisher Name Royal Society of Chemistry
Publication Country United Kingdom
International Standard Serial Number (ISSN) 20413203, 20413211
Coverage and History 2010, 2014-2022
Best Quartile Q4
Total Citations Received
(Last 3 Year)
68

About RSC Drug Discovery Series


RSC Drug Discovery Series is a book series published by Royal Society of Chemistry. This book series covers the area[s] related to Drug Discovery, etc. The coverage history of this book series is as follows: 2010, 2014-2022. The rank of this book series is 25709. This book series's impact score, h-index, and SJR are 0.28, 11, and 0.107, respectively. The ISSN of this book series is/are as follows: 20413203, 20413211.

The best quartile of RSC Drug Discovery Series is Q4. This book series has received a total of 68 citations during the last three years (Preceding 2022).


RSC Drug Discovery Series Impact Score 2022-2023


The latest impact score (IS) of the RSC Drug Discovery Series is 0.28. It is computed in the year 2023 as per its definition and based on Scopus data.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting


Impact Score Graph


Check below the Impact Score trends of RSC Drug Discovery Series. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.28
2021 0.41
2020 0.34
2019 0.37
2018 0.33
2017 0.42
2016 0.32
2015 0.00
2014 0.00

RSC Drug Discovery Series h-index


  Table Setting

The h-index of RSC Drug Discovery Series is 11. By definition of the h-index, this book series has at least 11 published articles with more than 11 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




RSC Drug Discovery Series ISSN


The International Standard Serial Number (ISSN) of RSC Drug Discovery Series is/are as follows: 20413203, 20413211.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

RSC Drug Discovery Series Ranking and SCImago Journal Rank (SJR)


The RSC Drug Discovery Series is ranked 25709 among 27955 Journals, Conferences, and Book Series. As per SJR, this book series is ranked 0.107.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


RSC Drug Discovery Series Publisher


Table Setting

The publisher of RSC Drug Discovery Series is Royal Society of Chemistry. The publishing house of this book series is located in the United Kingdom. Its coverage history is as follows: 2010, 2014-2022.


Call For Papers (CFPs)


Please check the official website of this book series to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of RSC Drug Discovery Series is RSC Drug Discov. Ser.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('RSC Drug Discov. Ser.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in RSC Drug Discovery Series


If your area of research or discipline is related to Drug Discovery, etc., please check the book series's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of RSC Drug Discovery Series?

The latest impact score of RSC Drug Discovery Series is 0.28. It is computed in the year 2023.


What is the h-index of RSC Drug Discovery Series?

The latest h-index of RSC Drug Discovery Series is 11. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of RSC Drug Discovery Series?

The latest SCImago Journal Rank (SJR) of RSC Drug Discovery Series is 0.107. It is calculated in the year 2023.


What is the ranking of RSC Drug Discovery Series?

The latest ranking of RSC Drug Discovery Series is 25709. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of RSC Drug Discovery Series?

RSC Drug Discovery Series is published by Royal Society of Chemistry. The publication country of this book series is United Kingdom.


What is the abbreviation of RSC Drug Discovery Series?

This standard abbreviation of RSC Drug Discovery Series is RSC Drug Discov. Ser..


Is "RSC Drug Discovery Series" a Journal, Conference or Book Series?

RSC Drug Discovery Series is a book series published by Royal Society of Chemistry.


What is the scope of RSC Drug Discovery Series?

The scope of RSC Drug Discovery Series is as follows:

  • Drug Discovery

For detailed scope of RSC Drug Discovery Series, check the official website of this book series.


What is the ISSN of RSC Drug Discovery Series?

The International Standard Serial Number (ISSN) of RSC Drug Discovery Series is/are as follows: 20413203, 20413211.


What is the best quartile for RSC Drug Discovery Series?

The best quartile for RSC Drug Discovery Series is Q4.


What is the coverage history of RSC Drug Discovery Series?

The coverage history of RSC Drug Discovery Series is as follows 2010, 2014-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Historia Journal Universidade Estadual Paulista 27560 7 0.02
Istanbul University - Journal of Electrical and Electronics Engineering Journal University of Istanbul 24654 0 0.00
Abacus Journal Wiley-Blackwell Publishing Ltd 8398 49 2.52
Modern Language Journal Journal Wiley-Blackwell 918 103 3.89
Palaeontographica Abteilung B: Palaeophytologie Book Series E. Schweizerbart'sche Verlagsbuchhandlung 15138 16 2.20
Libyan Studies Journal Cambridge University Press 16122 8 0.45
Tekstilec Trade Journal Faculty of Natural Sciences and Engineering, Tekstilec 19217 14 0.73
Population Review Journal Sociological Demography Press 17841 13 0.73
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Built Environment Journal Alexandrine Press 12797 43 1.15

Check complete list




RSC Drug Discovery Series Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 0.28
2021 0.41
2020 0.34
2019 0.37
2018 0.33
2017 0.42
2016 0.32
2015 0.00
2014 0.00



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

Expert Opinion on Therapeutic Targets
Taylor and Francis Ltd. | United Kingdom

Nucleic Acid Therapeutics
Mary Ann Liebert Inc. | United States

Drug Discovery Today
Elsevier Ltd. | United Kingdom

Current Opinion in Systems Biology
Elsevier Ltd. | United Kingdom

See All